Literature DB >> 19653261

Prognostic effect of inadvertent curettage without treatment delay in osteosarcoma.

Min Suk Kim1, Soo-Yong Lee, Wan Hyeong Cho, Won Seok Song, Jae-Soo Koh, Jun Ah Lee, Ji Young Yoo, Duk Seop Shin, Dae-Geun Jeon.   

Abstract

BACKGROUND: Unplanned primary surgery has been known to have a negative prognostic impact in osteosarcoma.
METHODS: We identified 20 osteosarcoma patients that had undergone inadvertent surgery followed by adequate treatment without delay, and compared the clinicopathologic characteristics of these 20 case patients with those of 365 patients who underwent incisional biopsy. For survival analysis, 40 control patients matched for tumor size at presentation, tumor location, age and gender were selected from these 365 patients.
RESULTS: Unusual initial clinicopathologic characteristics were frequently observed in the case patients, such as, an older age, a small tumor size, an unusual tumor location, and a lytic radiographic pattern. The 5-year overall survival rate in the case group was 89.4 +/- 7.1% and in the control group was 83.9 +/- 6.1%, and the 5-year event-free survival rate in the case group was 90.0 +/- 6.7% and in the control group was 76.8 +/- 6.8%. The log rank test revealed no survival difference between the case and control groups.
CONCLUSIONS: As is the case for soft tissue sarcoma, inadvertent extensive curettage with no ensuing treatment delay was found to have no detrimental effect on overall- or event-free survival in osteosarcoma. Further study using a larger sample size is needed to confirm our results.

Entities:  

Mesh:

Year:  2009        PMID: 19653261     DOI: 10.1002/jso.21371

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  5 in total

1.  Aggressive curettage of a chondroblastoma-like osteosarcoma of the proximal end of the tibia. A case report with seven-year follow-up.

Authors:  Luis Rafael Ramos Pascua; Paula Casas Ramos; Francisco Arias Martín; Francisco Miguel Izquierdo García
Journal:  Skeletal Radiol       Date:  2018-01-06       Impact factor: 2.199

2.  MFH of bone and osteosarcoma show similar survival and chemosensitivity.

Authors:  Dae-Geun Jeon; Won Seok Song; Chang-Bae Kong; Jung Ryul Kim; Soo-Yong Lee
Journal:  Clin Orthop Relat Res       Date:  2010-06-18       Impact factor: 4.176

3.  Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group.

Authors:  Tomoki Nakamura; Jun Sugaya; Norifumi Naka; Hiroshi Kobayashi; Tomotake Okuma; Toshiyuki Kunisada; Kunihiro Asanuma; Hedetatsu Outani; Shunji Nishimura; Hiroyuki Kawashima; Toru Akiyama; Taketoshi Yasuda; Shinji Miwa; Akihiro Sudo; Takafumi Ueda
Journal:  Cancer Manag Res       Date:  2020-10-12       Impact factor: 3.989

4.  Effect of Unplanned Therapy on the Prognosis of Patients with Extremity Osteosarcoma.

Authors:  Bing Wang; Ming Xu; Kai Zheng; Xiuchun Yu
Journal:  Sci Rep       Date:  2016-12-08       Impact factor: 4.379

5.  Identifying the prevalence, trajectory, and determinants of psychological distress in extremity sarcoma.

Authors:  Melissa H Tang; David J Castle; Peter F M Choong
Journal:  Sarcoma       Date:  2015-02-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.